Jump to content
World's Largest Herpes Support Group
Sign in to follow this  
Margaux

Research on Seroconversion Times

Recommended Posts

Margaux

I see a seminal article (Ashley-Morrow, Krantz, Wald, 2003) referenced very often in many threads concerning the time it takes to seroconvert. The test most frequently ordered by doctors is the Herpeselect, which takes 25 days on average til seroconversion is detected. It must be noted though, that this study does NOT use the reported exposure date as the date by which days are begun "counting" toward seroconversion. The study uses the date of the onset of symptoms. As we know, a primary outbreak, if it's going to happen on first exposure as opposed to lying dormant before ob'ing, happens 2-20 days after the exposure. If a person does not have symptoms until almost 3 weeks after an exposure, those three weeks are not factored into the 20 something days expected for seroconversion. I just figured I'd bring it up as I see a lot of people counting off weeks and wondering why they have not yet seroconverted.

Share this post


Link to post
Share on other sites
Margaux

The more I think about it, the more I realize what a limitation this is to their study. Knowing the time of seroconversion from the date of exposure might explain the vast spectrum of seroconversion days.

Share this post


Link to post
Share on other sites
death2herpes

besides the ambiguity of date of exposure, there is another point which i raise in this thread http://www.herpes-coldsores.com/messageforum/showthread.php?25112. some of the subjects characterized as "nonserocoverters" by date X were actually no longer followed up on so they distort the seroconversion percentages quoted. the times are actually shorter (or %ages higher, if you will).

Share this post


Link to post
Share on other sites
Margaux

Yes! I agree! The research is considered seminal because the literature in the field is so limited, however the study itself needs to be considered more in terms of its limitations than its findings. I am going to go read your thread now...

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

  • The Hive is Thriving!

    • Total Topics
      70,111
    • Total Posts
      473,860
  • Posts

    • TCBH
      Another company looking to create a vaccine.  http://www.bluewillow.com/bluewillow-biologics-awarded-patent-for-intranasal-genital-herpes-vaccine/ BlueWillow’s intranasal NanoVax platform elicits both mucosal and systemic immunity through its novel oil-in-water nanoemulsion (NE) adjuvant, offering a unique advantage to combat sexually transmitted infections (STIs) including genital herpes. The mucosal immunity elicited by intranasal NE vaccines provides critical protection against infections at the port of entry by which a pathogen enters the body. The intranasal NanoVax HSV vaccine has demonstrated safety and efficacy in both prophylactic and therapeutic animal models for genital herpes. In a prophylactic guinea pig study, the intranasal vaccine prevented genital herpes infection in 92 percent of animals vaccinated. Therapeutic study animals previously infected with genital herpes who received the BlueWillow vaccine reduced recurrent lesions and viral shedding by more than 50 percent compared to animals who received no treatment.
    • JHenry
      Cas, This is sooooooo exciting I may need a diaper!  How bout you?  😊
    • JHenry
      This is wonderful news!  Impressive dollars raised and the team is absolutely outstanding.  For those who have been dreaming of the Bill and Melinda Gates Foundation on our side, consider your prayers answered.  William Jacobs and Betsy Herold from Einstein have “sounded” extremely confident all along.  While maybe not just “around the corner” this is amazingly exciting!   If there was ever a person that possibly could be a force in “fast tracking” could it be Mr. Bill Gates?  While it may seem “so far off”, for those of us having been infected for 20+ years or more, it is still music to our ears, and the  glass is always half full-without hope you have nothing.   Never forget this line from Shawshank Redemption:                                           “Hope is a good thing, maybe the best of things, and no good thing ever dies”. 
    • LightafterDarkness
      Discussion thread on this news here:  
    • LightafterDarkness
      This is pretty impressive for a number of reasons: Average funding for a series A in biotech is around ~$50M but the median is around ~$30M as of 2018 The takeaway then is the XVax is at the higher end of the spectrum suggesting (1) High investor interest, (2) XVax is thinking big A robust set of investors- good to see that there are multiple names here rather than 1-2. Again, suggests robust interest from investors Note that the anchor investor (i.e., the biggest) is Adjuvent who are backed by Bill and Melinda Gates Foundation, good to see that HSV continues to be of interest to them (my theory: due to the link with HIV and Alzheimer now)   Overall everyone should be cheering this news given the impressive results seen with animal models. Still remember this is going to be a multi year process- I would hope to see a phase I in 2020
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.